Article preview reprinted from IN VIVO - April, 2009
Find out how in the world of medical devices, there are companies that begin by developing one thing and wind up doing something altogether different.
Article preview reprinted from IN VIVO - April, 2009
But few have taken the kind of path that Volcano has. Once a high-flying dynamo with dreams of striking it big in vulnerable plaque, Volcano has seen those dreams all but disappear. But instead of crashing to earth Icarus-like, Volcano is soaring, this time on the back of the unlikeliest of technologies, intravascular ultrasound (IVUS), and a business built on a number of opportunistic commercial moves made while still forging ahead in vulnerable plaque. Volcano's new vision: that of a therapy-guidance leader, a "theranostic company," that helps physicians understand whom, how, and when best to treat.
Purchase this article online as a PDF and receive it immediately via email. Questions? Call (800) 332-2181. 100% Satisfaction Guaranteed. Subscribe to IN VIVO.
Companies mentioned in this article:
Abbott Laboratories Inc.
Abbott Vascular Devices
Agilent Technologies Inc.
Boston Scientific Corp.
Cleveland Clinic
Fukuda Denshi Ltd.
General Electric Co.
GE Healthcare
Goodman Co. Ltd.
Johnson & Johnson
Cordis Corp.
Jomed NV
EndoSonics Corp.
LightLab Imaging LLC
Medtronic Inc.
Royal Philips Electronics NV
Siemens AG
St. Jude Medical Inc.
Radi Medical Systems
Terumo Corp.
Volcano Corp.
Axsun Technologies Inc.
IN VIVO delivers:
- Revealing, in-depth coverage of your competitors' strategies
- Incisive projections of future industry trends and their implications for your business
- Expert analysis of key industry developments
- Exclusive interviews with top industry executives and analysts
- In-depth examination of dealmaking, marketing, R&D, regulatory, and finance strategies -- those that were successful and those that missed the mark
- Subscribe to IN VIVO today!
